Gilead’s quarterly loss is narrower than expected

Gilead Sciences Inc.’s stock dipped 0.2% in after-hours shopping and selling Thursday, after the drug company’s adjusted first-quarter earnings modified into once narrower than expected…
Read More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button